Avidity Biosciences
RNA
$28.91
Share price
11.11%
Change (1 day)
156.98%
Change (1 year)
Categories
Market capitalization of Avidity Biosciences (RNA)
Market cap: $2.76 Billion
As of May 2024 Avidity Biosciences has a market cap of $2.76 Billion. This makes Avidity Biosciences the world's 3643th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Avidity Biosciences from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.76 B | 285.86% |
| 2023 | $0.71 B | -51.41% |
| 2022 | $1.47 B | 32.3% |
| 2021 | $1.11 B | 16.4% |
| 2020 | $0.95 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Avidity Biosciences was reported to be:
$2.76 Billion
$2.76 Billion
$2.76 Billion
$2.76 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $160.81 B | 5,716.49% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $94.43 B | 3,315.43% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $12.53 B | 353.53% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.39 B | -13.51% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.48 B | -82.63% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.97% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 295.38% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.94 B | -29.55% | 🇺🇸 USA |